4.6 Article

Radiation-Induced Dyspnea in Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy

Related references

Note: Only part of the references are listed.
Article Oncology

Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?

Feng-Ming (Spring) Kong et al.

Summary: SBRT has become the standard of care for inoperable early-stage non-small cell lung cancer, recurrent lung cancer, and pulmonary metastases. Risk of RILT, including radiation pneumonitis and pulmonary fibrosis, is associated with tumor size and location, and patients with interstitial lung disease appear to be especially susceptible. Safe treatment with a low rate of symptomatic RILT can be achieved by controlling the mean lung dose and the percentage of total lung volume receiving high radiation doses.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Oncology

Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer

Yongmei Liu et al.

Summary: This study investigated risk factors for radiation pneumonitis (RP) in NSCLC patients undergoing SBRT, finding that factors such as respiratory comorbidity history, previous thoracic radiation, and right lung location were significantly associated with RP2. A model combining clinical and dosimetric factors showed high predictive accuracy, suggesting that limiting mean lung dose can reduce lung toxicity risk.

RADIOTHERAPY AND ONCOLOGY (2021)

Editorial Material Oncology

Flogging a Dead Salmon? Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials

Jane Shortall et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Review Oncology

Stereotactic Radiation for Lung Cancer: A Practical Approach to Challenging Scenarios

Neal Andruska et al.

Summary: SBRT is an effective and well-tolerated treatment for medically inoperable early stage NSCLC patients, achieving superior local control and survival compared to conventional fractionated radiation. Its use has dramatically increased in the past 15 years and is now considered the standard of care for inoperable early stage NSCLC. Balancing patient and treatment factors is increasingly important in selecting optimal patients for SBRT, especially in more complex patient populations.

JOURNAL OF THORACIC ONCOLOGY (2021)

Article Oncology

Probing thoracic dose patterns associated to pericardial effusion and mortality in patients treated with photons and protons for locally advanced non-small-cell lung cancer

Laura Cella et al.

Summary: The study investigated thoracic dose-response patterns for pericardial effusion and mortality in locally advanced Non-Small-Cell Lung Cancer (NSCLC) patients treated with Intensity Modulated RT (IMRT) or Passive-Scattering Proton Therapy (PSPT). While non-dosimetric variables were selected for outcomes, the RT technique did not significantly affect the occurrence of pericardial effusion or overall survival. Voxel-Based Analyses highlighted clusters associated with pericardial effusion in heart and lungs, with no significant dosimetric patterns related to mortality identified.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Oncology

Radiation Pneumonitis in Thoracic Cancer Patients: Multi-Center Voxel-Based Analysis

Giuseppe Palma et al.

Summary: This study investigated dose-response patterns associated with radiation pneumonitis (RP) in thoracic cancer patients treated with different radiation modalities. Voxel-based analysis showed that lower parts of the lungs and the heart play a prominent role in RP development, providing valuable insights for therapeutic strategies. Connectograms also demonstrated the ability to differentiate between the main heart and lung substructures in radiobiological analysis.

CANCERS (2021)

Article Oncology

Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers

Janna Berg et al.

Summary: This study investigated changes in pulmonary function, symptoms, and radiological signs of pneumonitis in patients receiving stereotactic body radiation therapy for early-stage non-small cell lung cancer. Symptomatic radiation pneumonitis occurred in 18% of patients, while asymptomatic pneumonitis was observed in 39% based on radiology. Early decreases in FEV1 and DLCO may indicate the development of symptomatic radiation pneumonitis, which could be predicted by doses to critical lung volumes.

FRONTIERS IN ONCOLOGY (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Voxel-based analysis in radiation oncology: A methodological cookbook

G. Palma et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2020)

Article Oncology

Image-based Data Mining to Probe Dosimetric Correlates of Radiation-induced Trismus

William Beasley et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)

Article Multidisciplinary Sciences

Inter-patient image registration algorithms to disentangle regional dose bioeffects

Serena Monti et al.

SCIENTIFIC REPORTS (2018)

Article Oncology

Radiation-induced acute dysphagia

D. Alterio et al.

STRAHLENTHERAPIE UND ONKOLOGIE (2017)

Article Oncology

A Voxel-Based Approach to Explore Local Dose Differences Associated With Radiation-Induced Lung Damage

Giuseppe Palma et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Article Oncology

Predicting radiation-induced valvular heart damage

Laura Cella et al.

ACTA ONCOLOGICA (2015)

Article Oncology

Lack of a Dose-Effect Relationship for Pulmonary Function Changes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer

Matthias Guckenberger et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Article Oncology

Physiological Interaction of Heart and Lung in Thoracic Irradiation

Ghazaleh Ghobadi et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)

Article Oncology

A DOSE-VOLUME ANALYSIS OF RADIATION PNEUMONITIS IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH STEREOTACTIC BODY RADIATION THERAPY

R. Bryan Barriger et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)

Article Oncology

Biological mechanisms of normal tissue damage: Importance for the design of NTCP models

Klaus-Ruediger Trott et al.

RADIOTHERAPY AND ONCOLOGY (2012)

Article Oncology

Heart irradiation as a risk factor for radiation pneumonitis

Ellen X. Huang et al.

ACTA ONCOLOGICA (2011)